CSIMarket Company Name, Ticker, Competitors, else..


Adverum Biotechnologies Inc   (NASDAQ: ADVM)
Other Ticker:  
 

Adverum Biotechnologies Inc

ADVM's Fundamental analysis



Adverum Biotechnologies Inc 's sales fell in IV. Quarter 2024 from the same quarter a year ago.

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -2.45 %

Adverum Biotechnologies Inc net loss increased from $-24 millions, to $-61 millions in IV. Quarter 2024,

• More on ADVM's Growth


Adverum Biotechnologies Inc
realized a net loss in trailing twelve months.

Adverum Biotechnologies Inc realized cash reduction of $ 0 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 56.37.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.18.


• More on ADVM's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 3.58

Adverum Biotechnologies Inc
realized net loss in trailing twelve months.

Adverum Biotechnologies Inc realized cash outflow of $ 0per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 56.37.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.18.

Adverum Biotechnologies Inc Price to Book Ratio is at 0.8 lower than Industry Avg. of 18247.4. and higher than S&P 500 Avg. of 0.01

• More on ADVM's Valuation

•  Market Capitalization (Millions $) 56
•  Shares Outstanding (Millions) 20
•  Employees 121
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -131
•  Cash Flow (TTM) (Millions $) 0
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 3.58

•  Market Capitalization (Millions $) 56
•  Shares Outstanding (Millions) 20
•  Employees 121
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -131
•  Cash Flow (TTM) (Millions $) 0
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 5.73
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.33
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com